NeuMoDx Molecular Inc recalls NeuMoDx Flu A-B/RSV/SARS-CoV-2 Vantage Test Strip, Ref # 300900 (marketed under EUA202947). Distributed in boxes of 6 a…
- Recall date
- January 21, 2022
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- Z-0738-2022
- FDA classification
- Class II
- Brand / firm
- NeuMoDx Molecular Inc
- Sold / distributed
- US Nationwide distribution in the states of FL, MD, MI, NY.
Why it was recalled
A risk for product contamination was identified for the affected product lot. If used, there is an increased potential for SARS-CoV-2 false positive results when using the product.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
NeuMoDx Flu A-B/RSV/SARS-CoV-2 Vantage Test Strip, Ref # 300900 (marketed under EUA202947). Distributed in boxes of 6 assay strips in individual pouches. Box, pouch and strips all labeled with product name, ref #, lot #, and expiration date.
Get recall alerts
Free email alert whenever NeuMoDx Molecular Inc has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: NeuMoDx Molecular Inc